Dual ET A /ET B blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Dual ET A /ET B blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension

Published:2017-11 Issue:1 Volume:8 Page:1-15
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Nadeau Valerie¹²,Potus Francois¹²,Boucherat Olivier¹²³,Paradis Renee¹²,Tremblay Eve¹²,Iglarz Marc⁴,Paulin Roxane¹²³,Bonnet Sebastien¹²³,Provencher Steeve¹²³

Affiliation:

1. Pulmonary Hypertension Research Group

2. Institut universitaire de cardiologie et de pneumologie de Québec Research CenterLaval UniversityQuebec CityCanada

3. Department of MedicineLaval UniversityQuebecCanada

4. Drug Discovery DepartmentActelion Pharmaceuticals Ltd.AllschwilSwitzerland

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045893217741429

Reference60 articles.

1. Updated clinical classification of pulmonary hypertension;Simonneau G;J Am Coll Cardiol,2013

2. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT);Galie N;Eur Respir J,2015

3. The metabolic theory of pulmonary arterial hypertension;Paulin R;Circ Res,2014

4. Relevant issues in the pathology and pathobiology of pulmonary hypertension;Tuder RM;J Am Coll Cardiol,2013

5. Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis;Tuder RM;J Pathol,2001

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The biased apelin receptor agonist, MM07, reverses Sugen/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan;Frontiers in Pharmacology;2024-04-09

2. Pulmonary arterial hypertension drugs can partially restore altered angiogenic capacities in bmpr2‐silenced human lung microvascular endothelial cells;Pulmonary Circulation;2023-10

3. Macitentan in the Young—Mid-term Outcomes of Patients with Pulmonary Hypertensive Vascular Disease treated in a Pediatric Tertiary Care Center;Pediatric Drugs;2023-06-03

4. Exploring the failing right ventricle in pulmonary hypertension by cardiac magnetic resonance: An in vivo study utilizing Macitentan;Pulmonary Circulation;2022-07

5. Macitentan attenuates cardiovascular remodelling in infant rats with chronic lung disease;Journal of Translational Medicine;2022-02-05